Fangchao Zheng

3353 Shengcheng Street
Weifang, 262700, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China.

Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: January 19, 2026

The Identification of Novel Prognostic and Predictive Biomarkers in Breast Cancer via the Elucidation of Tumor Ecotypes Using Ecotyper.

The Identification of Novel Prognostic and Predictive Biomarkers in Breast Cancer via the Elucidation of Tumor Ecotypes Using Ecotyper.

Journal: Cancer innovation

Published: September 30, 2024

Potential prognostic value of HER2/CEP17 FISH ratio in HER2-positive non-metastatic breast cancer: a real-world study.

Potential prognostic value of HER2/CEP17 FISH ratio in HER2-positive non-metastatic breast cancer: a real-world study.

Journal: Discover oncology

Published: September 06, 2024

Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.

Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.

Journal: Clinical and translational medicine

Published: January 24, 2024

Effects and mechanism of astragalus polysaccharide on wound healing of deep partial-thickness burns in rats

Effects and mechanism of astragalus polysaccharide on wound healing of deep partial-thickness burns in rats

Journal: Zhonghua shao shang yu chuang mian xiu fu za zhi

Published: October 08, 2023

Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study.

Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study.

Journal: Clinical breast cancer

Published: August 08, 2023

Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.

Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.

Journal: eLife

Published: June 19, 2023

The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages.

The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages.

Journal: Cancer medicine

Published: February 21, 2023

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer.

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer.

Journal: Frontiers in genetics

Published: December 16, 2022

Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.

Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.

Journal: Annals of translational medicine

Published: October 20, 2022

Trastuzumab Deruxtecan for Breast Cancer.

Trastuzumab Deruxtecan for Breast Cancer.

Journal: The New England journal of medicine

Published: June 15, 2022

Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer.

Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer.

Journal: Experimental hematology & oncology

Published: May 24, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026